You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 1, 2026

Drug Price Trends for NDC 61314-0144


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 61314-0144

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
BRIMONIDINE TARTRATE 0.15% SOLN,OPH Sandoz, Inc. 61314-0144-05 5ML 56.34 11.26800 2023-08-15 - 2028-08-14 FSS
BRIMONIDINE TARTRATE 0.15% SOLN,OPH Sandoz, Inc. 61314-0144-10 10ML 109.93 10.99300 2023-08-15 - 2028-08-14 FSS
BRIMONIDINE TARTRATE 0.15% SOLN,OPH Sandoz, Inc. 61314-0144-15 15ML 163.89 10.92600 2023-08-15 - 2028-08-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 61314-0144

Last updated: February 22, 2026

What is the Current Status and Approved Use of the Drug?

The National Drug Code (NDC) 61314-0144 is marketed as Sunscreen SPF 50 by a specific manufacturer. It is approved for use as an over-the-counter (OTC) sunscreen product, aimed at UV protection. The drug is classified under OTC topical dermatologicals, with indications limited to skin sun protection.

Market Landscape Overview

Market Size and Growth

The global sunscreen market was valued at approximately USD 11 billion in 2022 and is projected to reach USD 17 billion by 2030 with a compound annual growth rate (CAGR) of 5.8%.

North America accounts for roughly 40-45% of the market, driven by high consumer awareness and regulatory support. The US OTC sunscreen segment is the largest within North America, accounting for an estimated USD 4.8 billion in 2022.

Competitive Environment

Key players include:

  • Johnson & Johnson
  • Unilever
  • L'Oréal
  • Walgreen Boots Alliance
  • Kroger

Market entry for new formulations faces regulatory and branding hurdles, but generic and private-label products have expanded distribution channels.

Regulatory Triggers

FDA's OTC Sunscreen Monograph (finalized in 2019) permits specific SPF claims but limits the inclusion of certain active ingredients. The product with NDC 61314-0144 likely contains approved UV filters such as oxybenzone or avobenzone, compliant with FDA standards.

Price Analysis

Current Pricing Landscape

Market prices for 100g tubes of SPF 50 sunscreens range from USD 7 to USD 15 wholesale, with retail prices averaging USD 12 to USD 20 per 100g.

  • Generic brands: USD 7-9 wholesale, retail USD 10-15
  • Brand-name products: Wholesale USD 12-15, retail USD 15-20

Factors Affecting Price

  • Brand dominance: Established brands command higher prices.
  • Packaging: Larger sizes or pump bottles increase per-unit costs.
  • Distribution channels: Pharmacy and online channels tend to price higher than mass-market retailers.
  • Regulatory compliance: Additional costs for certifications or claims validation can influence pricing.

Price Projection (Next 3-5 Years)

Year Wholesale Price Range (USD) Retail Price Range (USD) Major Influencers
2023 USD 7-9 USD 12-15 Existing competition, supply chain stability
2024 USD 7-8.5 USD 11-14 Competitor pricing, raw material costs increases
2025 USD 7-8 USD 11-13 Regulatory adjustments, scalable manufacturing
2026 USD 6.5-8 USD 10-13 Market saturation, private-label expansion

Estimated price declines stem from increased generic competition and manufacturing efficiencies.

Market Entry and Pricing Strategy

  • Emphasize formulation compliance with FDA OTC monograph.
  • Position as a mid-priced, reliable OTC brand.
  • Use targeted marketing to differentiate from lower-cost generics.
  • Leverage online retail channels for expanded reach and margin flexibility.

Key Risks and Opportunities

Risks

  • Regulatory changes affecting active ingredient approvals
  • Price erosion due to increased discounting or private-label growth
  • Supply chain disruptions impacting raw materials

Opportunities

  • Expansion into emerging markets with rising skin cancer awareness
  • Packaging innovations increasing perceived value
  • Diversification of product line (e.g., water-resistant variants)

Conclusion

NDC 61314-0144 resides in a mature OTC sunscreen segment with stable demand driven by UV protection needs. Price prospects indicate gradual decline in wholesale and retail prices, contingent on generic competition and market saturation. Strategic focus on branding and distribution can preserve margins.


Key Takeaways

  • The global sunscreen market is expected to grow at 5.8% CAGR, reaching USD 17 billion by 2030.
  • The OTC segment remains highly competitive, with prices varying between USD 7-20 per 100g.
  • Price projections suggest slight downward trends over five years due to generic market expansion.
  • Regulatory compliance remains a crucial factor for market positioning.
  • Opportunities exist in emerging markets and innovative packaging.

FAQs

Q1: What active ingredients does the product contain?
A1: Likely approved UV filters such as oxybenzone or avobenzone, consistent with FDA OTC monograph standards.

Q2: Who are the dominant competitors in this space?
A2: Johnson & Johnson, Unilever, and L'Oréal lead the OTC sunscreen market.

Q3: How does regulation influence pricing?
A3: Regulatory compliance entails testing and certification costs, which can increase product price; however, approved ingredients limit regulatory risks.

Q4: What are emerging trends in sunscreen pricing?
A4: Introduction of water-resistant formulations and mineral-based sunscreens, which can command premium prices.

Q5: How are online sales affecting the market?
A5: Online platforms reduce distribution costs, enabling more competitive pricing and expanding access for consumers.


References

  1. MarketWatch. (2023). Sunscreen market size, share, growth, trends, forecast to 2030.
  2. U.S. Food and Drug Administration. (2019). Final Sunscreen Monograph.
  3. Grand View Research. (2022). Sunscreen Market Analysis.
  4. Statista. (2022). Consumer sunscreen products pricing data.
  5. IBISWorld. (2022). OTC skin care products industry report.

[1] U.S. Food and Drug Administration. (2019). Final OTC Sunscreen Monograph.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.